Clinical trial
Impact of Renal Denervation in Patients With Coronary Microvascular Dysfunction: Study Design and Rationale
NCT05994729 is registered in ClinicalTrials.gov with Aurelia Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Renal Denervation in Patients With Coronary Microvascular Dysfunction: Study Design and Rationale
- Lead sponsor
- Aurelia Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 87 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
coronary microvascular dysfunction, hypertensive heart disease, resistant hypertension